194 related articles for article (PubMed ID: 10189135)
1. Predictors of cancer progression in T1a prostate adenocarcinoma.
Cheng L; Bergstralh EJ; Scherer BG; Neumann RM; Blute ML; Zincke H; Bostwick DG
Cancer; 1999 Mar; 85(6):1300-4. PubMed ID: 10189135
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
Abaza R; Diaz LK; Laskin WB; Pins MR
J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
[TBL] [Abstract][Full Text] [Related]
3. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of T1a-T1b prostate cancer].
Liu Z; Luo C; Hu S; Fan Y; Liu ZH; Yang XY; Shen Q; Liu LB; Han WK; Zhou LQ; Yu W; He Q; Zhang Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):812-816. PubMed ID: 27752161
[TBL] [Abstract][Full Text] [Related]
5. An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.
Rajab R; Fisher G; Kattan MW; Foster CS; Møller H; Oliver T; Reuter V; Scardino PT; Cuzick J; Berney DM;
Mod Pathol; 2011 Jan; 24(1):58-63. PubMed ID: 20834240
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
Pacelli A; Bostwick DG
Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
9. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
Poulos CK; Daggy JK; Cheng L
Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065
[TBL] [Abstract][Full Text] [Related]
10. Extranodal extension in lymph node-positive prostate cancer.
Cheng L; Pisansky TM; Ramnani DM; Leibovich BC; Cheville JC; Slezak J; Bergstralh EJ; Zincke H; Bostwick DG
Mod Pathol; 2000 Feb; 13(2):113-8. PubMed ID: 10697266
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
Bostwick DG; Qian J; Pacelli A; Zincke H; Blute M; Bergstralh EJ; Slezak JM; Cheng L
J Urol; 2002 Sep; 168(3):1204-11. PubMed ID: 12187268
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of patients with stage T1a prostate cancer.
Chen WM; Yang CR; Ou YC; Cheng CL; Kao YL; Ho HC; Su CK; Chiu KY; Chen JT
J Chin Med Assoc; 2003 Apr; 66(4):236-40. PubMed ID: 12854876
[TBL] [Abstract][Full Text] [Related]
13. Operative course of transurethral resection of the prostate and progression of prostate cancer.
Trygg G; Ekengren J; Farahmand BY; Persson PG; Hahn RG
Urol Int; 1998; 60(3):169-74. PubMed ID: 9644788
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
[TBL] [Abstract][Full Text] [Related]
15. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort.
Barayan GA; Brimo F; Bégin LR; Hanley JA; Liu Z; Kassouf W; Aprikian AG; Tanguay S
BJU Int; 2014 Dec; 114(6b):E99-E104. PubMed ID: 24684511
[TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
[TBL] [Abstract][Full Text] [Related]
18. Influence of pathological factors on oncological outcomes after robot-assisted radical prostatectomy for localized prostate cancer: Results of a prospective study.
Kozal S; Peyronnet B; Cattarino S; Seisen T; Comperat E; Vaessen C; Mozer P; Renard-Penna R; Cussenot O; Rouprêt M; Drouin SJ
Urol Oncol; 2015 Jul; 33(7):330.e1-7. PubMed ID: 25998747
[TBL] [Abstract][Full Text] [Related]
19. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
Blute ML; Bergstralh EJ; Iocca A; Scherer B; Zincke H
J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379
[TBL] [Abstract][Full Text] [Related]
20. Relationship of pretreatment transurethral resection of the prostate to survival without distant metastases in patients treated with 125I-implantation for localized prostatic cancer.
Fowler JE; Fisher HA; Kaiser DL; Whitmore WF
Cancer; 1984 May; 53(9):1857-63. PubMed ID: 6704917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]